Midpoint Transverse Process to Pleura (MTP) Block vs Erector Spinae Plane (ESP) Block for Acute Herpes Zoster (HZ) Pain
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 90 people, planned
- Started
- 1 Jul 2026
- Expected to end
- 1 Jun 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Midpoint transverse process to pleura block
- Erector spinae plane block
- Record updated
- 29 July 2026
Who can take part
- Age
- 21 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Age 21-60 years
- Both sexes
- American Society of Anesthesiologists (ASA) physical status I-II
- Acute thoracic herpes zoster within 30 days of rash onset
- Moderate to severe pain [numeric rating scale (NRS)≥4]
Who cannot take part
- Coagulopathy or anticoagulant therapy
- Previous thoracic surgery deformity
- Infection at puncture site
- Allergy to study drugs
- Severe psychiatric illness or inability to assess pain
- Chronic diseases as renal, hepatic, malignancy
- Patients with chronic disease need analgesia
- Refusal to participate
- Uncontrolled Diabetic patient
- Patients are coming for more than 3 months (after healing of rash)
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 60 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to compare the analgesic efficacy and safety of ultrasound-guided midpoint transverse process block versus ultrasound-guided erector spinae plane block in patients suffering from thoracic herpes zoster pain.
The 2 groups in the trial
- Group MTPOther group
Patients will receive ultrasound-guided midpoint transverse process to pleura block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.
Treatment: Midpoint transverse process to pleura block
- Group ESPOther group
Patients will receive ultrasound -guided erector spinae plane block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.
Treatment: Erector spinae plane block
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison Between Midpoint Transverse Process to Pleura (MTP) Block vs Erector Spinae Plane (ESP) Block for Acute Herpes Zoster (HZ) Pain
- Criteria questions
- Built from NCT07732556, who can take part
- Record updated
- 29 July 2026